18 moTarget to Candidate

AI-Accelerated Drug Discovery

Insilico Medicine
Drug DiscoveryGenerative AI

Insilico Medicine uses AI to identify drug targets and design novel molecules, reducing the time from target to preclinical candidate from years to months.

Quick Facts

Industry

Life Sciences

Vendor

Internal

Tags

Drug Discovery, Generative AI

Case Tier

Hero Case Study

How AI Adoption Engineering Drives Results

This case study exemplifies the principles of Bold AI Leadership. Enterprise AI success comes from understanding organizational readiness, building cross-functional alignment, and creating sustainable adoption patterns.

Learn Our Methodology

More Results From Life Sciences

Explore other AI success stories from the Life Sciences industry.

Life Sciences

AI for Vaccine Development

Pfizer

Pfizer used AI throughout COVID-19 vaccine development, from candidate selection to manufacturing optimization, helping deliver vaccines in record time.

Vaccine DevelopmentManufacturing
View Details
Life Sciences

AI-Driven Drug Discovery

Roche

Roche uses AI to analyze molecular data and predict drug efficacy, accelerating the discovery of new treatments for cancer and other diseases.

Drug DiscoveryMolecular Analysis
View Details
Explore All Case Studies

Ready to Achieve Similar Results?

Let us help you build AI capability that delivers measurable outcomes for your organization.

Book a Consultation